tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences (CHRS) Revenue

Compare
1,582 Followers

Coherus Biosciences Revenue

Coherus Biosciences had a revenue of 54.14M in the quarter ending Dec 31, 2024, with -23.50%. This bring the company's revenue in the last twelve months to 266.96M, Increased -12.28%. In the fiscal year ending Dec 31, 2024, Coherus Biosciences had annual revenue of 266.96M with 3.78% growth.
Revenue (ttm)
266.96M
Revenue Growth
3.78%
P/S Ratio
0.40
Revenue/Employee
$1,170,877
Employees
228
Market Cap
$107.77M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024266.96M9.72M+3.78%
Dec 31, 2023257.24M46.20M+21.89%
Dec 31, 2022211.04M-115.51M-35.37%
Dec 31, 2021326.55M-149.27M-31.37%
Dec 31, 2020475.82M119.75M+33.63%
Dec 31, 2019356.07M354.51M+22,783.74%
Dec 31, 20181.56M0.000.00%
Dec 31, 20171.56M-188.55M-99.18%
Dec 31, 2016190.11M160.06M+532.82%
Dec 31, 201530.04M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis